About Latisse: Why Latisse?
Latisse: Why Latisse details the first and only FDA-approved prescription treatment for inadequate eyelashes, bimatoprost ophthalmic solution 0.03%.
NAP.BIZ VERIFIED
View NAP Vault Profile →NAP-BE5C0062
✓ Verified 2026-03-05View NAP Vault →
Structured data
Type:MedicalBusiness
Area:United States
Hours:Mo-Fr 08:00-17:00
Knows about
Eyelash TreatmentBimatoprostFDA-Approved MedicationDermatology
DirJournal Perspective
This listing focuses on Latisse, the FDA-approved prescription treatment for eyelash enhancement using bimatoprost ophthalmic solution 0.03%. Potential clients should note this listing has been active for one year but is NAP verified and has no customer reviews to assess service quality.